Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30014238
Basic Information
VIS ID
TVIS30014238
Fusion event
HIV-RNF157 integration
Validated
Yes
Detection method
invPCR
Data source
download(RID)
Sample type
PBMC
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2007
PubMed ID
17262715
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr17
Cytoband
q25.1
Reference genome
GRCh37/hg19
Start
74227757/76231676 (Hg38)
End
74227757/76231676 (Hg38)
Orient
+
Location type
Intronic
Target gene
RNF157
miRNAs that regulate target gene
hsa-mir-335-5p
;
hsa-mir-18a-5p
;
hsa-mir-6880-5p
;
hsa-mir-6870-5p
;
hsa-mir-7111-5p
;
hsa-mir-5698
;
hsa-mir-4723-5p
;
hsa-mir-6825-5p
;
hsa-mir-6883-5p
;
hsa-mir-6785-5p
;
hsa-mir-4728-5p
;
hsa-mir-149-3p
;
hsa-mir-7106-5p
;
hsa-mir-4763-3p
;
hsa-mir-1207-5p
;
hsa-mir-6797-5p
;
hsa-mir-1249-5p
;
hsa-mir-766-5p
;
hsa-mir-6077
;
hsa-mir-6722-3p
;
hsa-mir-1909-3p
;
hsa-mir-6133
;
hsa-mir-6130
;
hsa-mir-6129
;
hsa-mir-6127
;
hsa-mir-4510
;
hsa-mir-4419a
;
hsa-mir-4784
;
hsa-mir-3150b-3p
;
hsa-mir-605-3p
;
hsa-mir-6798-5p
;
hsa-mir-6794-5p
;
hsa-mir-4716-3p
;
hsa-mir-4756-5p
;
hsa-mir-4739
;
hsa-mir-1321
;
hsa-mir-6893-5p
;
hsa-mir-940
;
hsa-mir-6808-5p
;
hsa-mir-3714
;
hsa-mir-2355-3p
;
hsa-mir-3674
;
hsa-mir-676-3p
;
hsa-mir-6772-3p
;
hsa-mir-580-3p
;
hsa-mir-7975
;
hsa-mir-4473
;
hsa-mir-636
;
hsa-mir-4732-5p
;
hsa-mir-6832-5p
;
hsa-mir-3907
;
hsa-mir-4448
;
hsa-mir-4268
;
hsa-mir-539-5p
;
hsa-mir-6730-5p
;
hsa-mir-6080
;
hsa-mir-520f-3p
;
hsa-mir-302c-3p
;
hsa-mir-512-3p
;
hsa-mir-5584-5p
;
hsa-mir-6873-5p
;
hsa-mir-4735-3p
;
hsa-mir-18b-5p
;
hsa-mir-6809-3p
;
hsa-mir-6833-3p
;
hsa-mir-4768-5p
;
hsa-mir-3191-5p
;
hsa-mir-1248
;
hsa-mir-498
;
hsa-mir-4279
;
hsa-mir-1200
;
hsa-mir-6778-3p
;
hsa-mir-4682
;
hsa-mir-1976
;
hsa-mir-3653-5p
;
hsa-mir-6747-3p
;
hsa-mir-6727-3p
;
hsa-mir-4722-3p
;
hsa-mir-544b
;
hsa-mir-4324
;
hsa-mir-660-3p
;
hsa-mir-33b-5p
;
hsa-mir-33a-5p
;
hsa-mir-4430
;
hsa-mir-3652
;
hsa-mir-4634
;
hsa-mir-122-5p
;
hsa-mir-504-3p
;
hsa-mir-3135b
;
hsa-mir-6868-3p
;
hsa-mir-1237-3p
;
hsa-mir-150-5p
;
hsa-mir-4532
;
hsa-mir-1247-3p
;
hsa-mir-6814-5p
;
hsa-mir-4650-5p
;
hsa-mir-1972
;
hsa-mir-15a-3p
;
hsa-mir-4740-3p
;
hsa-mir-1306-5p
Nearest miRNA
hsa-mir-10226/Upstream/133600; hsa-mir-1250/Downstream/504774;
Nearest TSS
ENST00000595228/Upstream/64594;
ENST00000587913/Downstream/8625;
Nearest CpG islands
None/Target,
chr17-CpG: 26/Upstream/4625
,
chr17-CpG: 190/Downstream/8001
Upstream sequence
agcccaggagtagaagatcagcctgggtaatatagtgagaccccatctccacttatttaaaaaagaaaaaaaaaAGTCTACCTTCAATGCCTTTTGCTAC
Downstream sequence
CAAGAACCCCACCCTTTCAATCATCAAGCTCTTGTCTTTATTTTATCCAAAAGGCACAAACCCCTCTGTGCTGTTAtttttaagagctttattgaagtat
Reference
Ikeda, T., et al. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy. J Infect Dis,2007, 195(5): 716-725.
Sample Information
×
Sample type
PBMC
Gender
Female
CpG Island Information
×
Download
Curate